Pharmacokinetics
- Business Wire
Takeda Announces U.S. FDA Grants Priority Review for New Drug Application for Mobocertinib (TAK-788) as a Treatment for EGFR Exon20 Insertion+ Metastatic Non-Small Cell Lung Cancer
− Prescription Drug User Fee Act (PDUFA) Target Action Date Set for October 26, 2021 CAMBRIDGE, Mass. & OSAKA, Japan–(BUSINESS…
Read More » - COVID-19
New SARS-CoV-2 Neutralizing Antibody enters Clinical Phase
Cologne, Marburg, Braunschweig & Ingelheim, Germany: Cologne University Hospital (UKK), University of Marburg (UMR), the German Center for Infection Research…
Read More » - India
All India Institute of Ayurveda signes MoU with Amity University for Ayurveda Research
Continuing with the policy of Ministry of AYUSH of forging partnerships for promoting and developing the AYUSH Systems of Healthcare,…
Read More »